Last updated on October 2015

Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy People

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Diabetes Mellitus | Gastroparesis
  • Age: Between 40 - 80 Years
  • Gender: Male or Female
  • Other:
    Healthy subjects:
    Male or female (females using appropriate contraceptive method or willing to
    undergo pregnancy test)
    Body Mass Index (BMI) 19 - 30 kg/m2
    Type 2 Diabetic Patients:
    As per "healthy subjects"
    Type 2 diabetes (World Health Organisation (WHO) criteria) managed by diet alone
    or on metformin
    Glycated haemoglobin >6.0% and <8.5%

You may not be eligible for this study if the following are true:

  • Subjects with a history of severe respiratory, cardiovascular, hepatic and/or renal
    disease (severe in that the social or physical manifestations of the disease, or
    living with the condition, impact negatively and significantly on the individuals'
    ability to lead a normal day to day life), chronic alcohol abuse or epilepsy
    (excluded by history) or if iron status, or liver function tests are outside the
    following ranges:
    Alanine aminotransferase (ALT) 0 - 55 U/L
    Alkaline phosphatase 30 - 110 U/L
    Aspartate transaminase 0 - 45 U/L
    Amylase and/or lipase >3 x ULN
    Bilirubin 6 - 24 mmol/L
    Ferritin 15 - 200 ng/mL (females); 30 - 300 ng/mL (males)
    Haemoglobin 115 - 155 g/L (females); 135 - 172 g/L (males)
    Subjects with a creatinine clearance cut-off of <50 ml/min
    Subjects requiring medication likely to influence blood pressure or gastrointestinal
    Subjects with a past history of gastrointestinal disease, including known
    gastroparesis, significant upper gastrointestinal symptoms and previous gastric
    Subjects with a past history of unexplained pancreatitis, chronic pancreatitis,
    Subjects with a current or prior history of c-cell carcinoma
    Smoking > 10 cigarettes/day
    Alchohol consumption > 20 g/day
    Subjects who have donated blood in the previous 12 weeks
    Women of childbearing potential with no effective contraceptive method (defined as
    premenopausal, not surgically sterile women for at least 3 months prior to the time
    of screening) must have a confirmed negative urine B-hCG pregnancy test at screening
    visit. They must also use an effective contraceptive method throughout the study, and
    agree to repeat urine pregnancy test at designated visits.

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.